RankingsPricing
  1. JP-listed companies
  2. Carna Biosciences, Inc.
  3. Financials
  4. Long-term debt, non-current

Carna Biosciences, Inc.JP:4572

Market cap
¥7.7B
P/E ratio
-3.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndLong-term debt, non-current (Million JPY)YoY (%)
Dec 31, 20248-70.39%
Dec 31, 202328-80.86%
Dec 31, 2022148-44.71%
Dec 31, 2021268+49.20%
Dec 31, 2020180-47.37%
Dec 31, 2019342+1.19%
Dec 31, 2018338+13.29%
Dec 31, 2017298-16.13%
Dec 31, 2016355+139.73%
Dec 31, 2015148+21.59%
Dec 31, 2014122

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)